(Q74413511)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12098515%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Increased levels of IL-15 mRNA in relapsing--remitting multiple sclerosis attacks (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12098515%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

C Blanco-Jerez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12098515%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J F Plaza

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12098515%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J Masjuan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12098515%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

L M Orensanz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12098515%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J C Alvarez-Cermeño

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12098515%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 July 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12098515%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroimmunology

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12098515%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12098515%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12098515%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

90-94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12098515%20AND%20SRC:MED&resulttype=core&format=json

Transcriptional analysis of multiple sclerosis brain lesions reveals a complex pattern of cytokine expression

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

The adhesion molecule and cytokine profile of multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

IL-15, a novel cytokine produced by human fetal membranes, is elevated in preterm labor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

The effects of high-dose methylprednisolone on gadolinium-enhanced magnetic resonance imaging and cerebrospinal fluid measurements in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83-99).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

Tumor necrosis factor identified in multiple sclerosis brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

Active MRI lesion appearance in MS patients is preceded by fluctuations in circulating T-helper 1 and 2 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

IL-15 mRNA expression is up-regulated in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis (MS)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

Megadose corticosteroids in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

Interleukin-15 gene expression in human astrocytes and microglia in culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

The expression of integrins on activated T-cells in multiple sclerosis. Effect of intravenous methylprednisolone treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

The role of interleukin–15 in T–cell migration and activation in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

Cytokines in neuroinflammatory disease: role of myelin autoreactive T cell production of interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

Levels of interleukin-15-expressing blood mononuclear cells are elevated in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

Comparison of the effects of oral versus intravenous methylprednisolone regimens on peripheral blood T lymphocyte adhesion molecule expression, T cell subsets distribution and TNF alpha concentrations in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

Improvement in motor evoked potentials and clinical course post-steroid therapy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

Expression pattern of activation and adhesion molecules on peripheral blood CD4+ T-lymphocytes in relapsing-remitting multiple sclerosis patients: a serial analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900146-7

7 January 2021

10.1016/S0165-5728(02)00146-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12098515%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference